Provided by Tiger Fintech (Singapore) Pte. Ltd.

Achieve Life Sciences, Inc.

4.20
+1.1236.36%
Post-market: 4.07-0.1293-3.08%19:59 EDT
Volume:15.97M
Turnover:65.53M
Market Cap:214.64M
PE:-2.88
High:4.44
Open:3.97
Low:3.71
Close:3.08
52wk High:5.31
52wk Low:1.84
Shares:51.10M
Float Shares:44.42M
Volume Ratio:10.92
T/O Rate:35.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4583
EPS(LYR):-1.2418
ROE:-120.11%
ROA:-50.63%
PB:5.15
PE(LYR):-3.38

Loading ...

Company Profile

Company Name:
Achieve Life Sciences, Inc.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
25
Office Location:
22722 29th Dr. SE,Suite 100,Bothell,Washington,United States
Zip Code:
98021
Fax:
- -
Introduction:
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol Achieve Life Sciences, Inc. is based in Vancouver, Canada.

Directors

Name
Position
Richard Stewart
Director, Chief Executive Officer
Thomas B. King
Director, Interim Executive Chairman
Bridget Martell
Director
Kristen Slaoui
Director
Nancy R. Phelan
Director
Stuart Duty
Director
Thomas Sellig
Director

Shareholders

Name
Position
Richard Stewart
Director, Chief Executive Officer
Mark Oki
Chief Financial Officer
Jaime Xinos
Chief Commercial Officer
Thomas B. King
Director, Interim Executive Chairman